Magali Chartier
Sherbrooke, QC J1H5N4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A neurotensin receptor type 1-derived pepducin acts as a biased allosteric modulator to regulate target receptor function.
Journal: Acta pharmaceutica Sinica. B
Published: August 01, 2025
Design, Synthesis, and In Vitro Characterization of Proteolytically-Stable Opioid-Neurotensin Hybrid Peptidomimetics.
Journal: ACS pharmacology & translational science
Published: April 23, 2024
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid-Free Analgesics.
Journal: Angewandte Chemie (International ed. in English)
Published: March 27, 2024
Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 22, 2021
Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.
Journal: Journal of medicinal chemistry
Published: February 04, 2021
Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia.
Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia.
Journal: Behavioural brain research
Published: July 01, 2020
Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain.
Journal: Pharmacological research
Published: October 23, 2019
Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.
Journal: ACS chemical neuroscience
Published: October 08, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026